Ukomadu, C. & Dutta, A. p21-dependent inhibition of colon most cancers cell progress by mevastatin is unbiased of inhibition of G1 cyclin-dependent kinases. J. Biol. Chem. 278, 43586–43594 (2003).
Shon, Y. H. & Nam, Ok. S. Chemopreventive impact of protein extract of Asterina pectinifera in HT-29 human colon adenocarcinoma cells. Arch. Pharm. Res. 29, 209–212 (2006).
Alhakamy, N. A. et al. Chitosan-based microparticles improve ellagic acid’s colon concentrating on and proapoptotic exercise. Pharmaceutics 12, 1–14 (2020).
Jain, S. Ok. & Jain, A. Goal-specific drug launch to the colon. Skilled Opin. Drug Deliv. 5, 483–498 (2008).
Aiello, P. et al. Medicinal crops within the prevention and therapy of colon most cancers. Oxid. Med. Cell. Longev. 2019, 2075614 (2019).
Reddy, B. S. Weight-reduction plan and colon most cancers: Proof from human and animal mannequin research. in Weight-reduction plan, Diet, and Most cancers: A Crucial Analysis 47–66 (CRC Press, 2018). https://doi.org/10.1201/9781351071406-4.
Shirin, H. et al. Lovastatin augments sulindac-induced apoptosis in colon most cancers cells and potentiates chemopreventive results of sulindac. Gastroenterology 117, 838–847 (1999).
Alhakamy, N. A. et al. Piceatannol-loaded emulsomes exhibit enhanced cytostatic and apoptotic actions in colon most cancers cells. Antioxidants 9, 419 (2020).
Fahmy, U. A. Augmentation of fluvastatin cytotoxicity in opposition to prostate carcinoma PC3 cell line using alpha lipoic-ellagic acid nanostructured lipid service method. AAPS PharmSciTech 19, 3454–3461 (2018).
Alhakamy, N. A. et al. Fluvastatin-Loaded Emulsomes Exhibit Improved Cytotoxic and Apoptosis in Prostate Most cancers Cells. AAPS PharmSciTech 22, (2021).
Gazzerro, P. et al. Pharmacological actions of statins: A vital appraisal within the administration of most cancers. Pharmacol. Rev. 64, 102–146 (2012).
Shay, Ok. P., Moreau, R. F., Smith, E. J., Smith, A. R. & Hagen, T. M. Alpha-lipoic acid as a dietary complement: Molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta Gen. Subj. 1790, 1149–1160 (2009).
Dozio, E. et al. The pure antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast most cancers cells. Eur. J. Pharmacol. 641, 29–34 (2010).
Aldawsari, H. M. et al. Growth of a fluvastatin-loaded self-nanoemulsifying system to maximise therapeutic efficacy in human colorectal carcinoma cells. J. Drug Deliv. Sci. Technol. 46, 7–13 (2018).
El-Helw, A.-R. M. A.-R. M. & Fahmy, U. A. Enchancment of fluvastatin bioavailability by loading on nanostructured lipid carriers. Int. J. Nanomed. 10, 5797–5804 (2015).
Graaf, M. R., Richel, D. J., van Noorden, C. J. F. & Guchelaar, H. J. Results of statins and farnesyltransferase inhibitors on the event and development of most cancers. Most cancers Deal with. Rev. 30, 609–641 (2004).
Demierre, M. F., Higgins, P. D. R., Gruber, S. B., Hawk, E. & Lippman, S. M. Statins and most cancers prevention. Nat. Rev. Most cancers 5, 930–942 (2005).
Campbell, M. J. et al. Breast most cancers progress prevention by statins. Most cancers Res. 66, 8707–8714 (2006).
Brown, A. J. Ldl cholesterol, statins and most cancers. Clin. Exp. Pharmacol. Physiol. 34, 135–141 (2007).
Chan, Ok. Ok. W., Oza, A. M. & Siu, L. L. The statins as anticancer brokers. Clin. Most cancers Res. 9, 10–19 (2003).
Carlin, C. M., Peacock, A. J. & Welsh, D. J. Fluvastatin inhibits hypoxic proliferation and p38 MAPK exercise in pulmonary artery fibroblasts. Am. J. Respir. Cell Mol. Biol. 37, 447–456 (2007).
Al-Rabia, M. W. et al. Repurposing of sitagliptin-melittin optimized nanoformula in opposition to sars-cov-2: Antiviral screening and molecular docking research. Pharmaceutics 13, 1–21 (2021).
Gajski, G. & Garaj-Vrhovac, V. Melittin: A lytic peptide with anticancer properties. Environ. Toxicol. Pharmacol. 36, 697–705 (2013).
Kong, G. M. et al. Melittin induces human gastric most cancers cell apoptosis through activation of mitochondrial pathway. World J. Gastroenterol. 22, 3186–3195 (2016).
Liu, S. et al. Melittin prevents liver most cancers cell metastasis by means of inhibition of the Rac1-dependent pathway. Hepatology 47, 1964–1973 (2008).
Mahmoudi, H., Alikhani, M. Y. & Imani Fooladi, A. A. Synergistic antimicrobial exercise of melittin with clindamycin on the expression of encoding exfoliative toxin in Staphylococcus aureus. Toxicon 183, 11–19 (2020).
Al-Rabia, M. W. et al. Boosting curcumin exercise in opposition to human prostatic most cancers PC3 cells by using scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Deliv. 29, 807–820 (2022).
Gomes, F. P. et al. Growth and validation of stability-indicating hplc strategies for quantitative willpower of pravastatin, fluvastatin, atorvastatin, and rosuvastatin in prescribed drugs. Anal. Lett. 42, 1784–1804 (2009).
Fahmy, U. A., L. Alaofi, A., Awan, Z. A., Alqarni, H. M. & Alhakamy, N. A. Optimization of thymoquinone-loaded coconut oil nanostructured lipid carriers for the administration of ethanol-induced ulcer. AAPS PharmSciTech 21, 1–10 (2020).
Alhakamy, N. A. et al. Encapsulation of lovastatin in zein nanoparticles reveals enhanced apoptotic exercise in HepG2 Cells. Int. J. Mol. Sci. 20, E5788 (2019).
Fahmy, U. A. et al. The encapsulation of febuxostat into emulsomes strongly enhances the cytotoxic potential of the drug on HCT 116 colon most cancers cells. Pharmaceutics 12, 1–17 (2020).
Van Engeland, M., Nieland, L. J. W., Ramaekers, F. C. S., Schutte, B. & Reutelingsperger, C. P. M. Annexin V-affinity assay: A evaluate on an apoptosis detection system primarily based on phosphatidylserine publicity. Cytometry 31, 1–9 (1998).
Naseri, M. H. et al. Up regulation of Bax and down regulation of Bcl2 throughout 3-NC mediated apoptosis in human most cancers cells. Most cancers Cell Int. 15, 55 (2015).
Chipuk, J. E. et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (80-. ). 303, 1010–1014 (2004).
Liu, Q. S. et al. Ellagic acid protects in opposition to neuron harm in ischemic stroke by means of regulating the ratio of Bcl-2/Bax expression. Appl. Physiol. Nutr. Metab. 42, 855–860 (2017).
Mahmood, T. & Yang, P. C. Western blot: Method, idea, and bother capturing. N. Am. J. Med. Sci. 4, 429–434 (2012).
Eid, B. G. et al. Melittin and diclofenac synergistically promote wound therapeutic in a pathway involving TGF-β1. Pharmacol. Res. 175, (2022).
Ahmed, O. A. A. et al. Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a possible transdermal drug supply system: In vitro and ex vivo research. Int. J. Nanomed. 14, 33–43 (2018).
Badr-Eldin, S. M. et al. Optimized semisolid self-nanoemulsifying system primarily based on glyceryl behenate: A possible nanoplatform for enhancing antitumor exercise of raloxifene hydrochloride in MCF-7 human breast most cancers cells. Int. J. Pharm. 600, 120493 (2021).
Ali, N. et al. Fluvastatin interferes with hepatitis C virus replication through microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS ONE 8, 1–10 (2013).
Elsayed, M. et al. Synergistic antiproliferative results of zoledronic acid and fluvastatin on human pancreatic most cancers cell traces: An in Vitro research. Biol. Pharm. Bull. 39, 1238–1246 (2016).
Zhang, W., Wu, J., Zhou, L., Xie, H.-Y. & Zheng, S.-S. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells by means of mitochondria-operated pathway. Indian J. Exp. Biol. 48, 1167–1174 (2010).
Bocci, G. et al. Fluvastatin synergistically enhances the antiproliferative impact of gemcitabine in human pancreatic most cancers MIAPaCa-2 cells. Br. J. Most cancers 93, 319–330 (2005).
Chang, S. N., Kim, H. J. & Lee, Ok. C. Melittin, a serious polypeptide of bee venom, will increase radiosensitivity of breast most cancers in vitro and in vivo. Int. J. Radiat. Oncol. 108, e527 (2020).
Lee, C. et al. Focusing on of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide. J. Immunother. Most cancers 7, 147 (2019).
Jin, H. et al. Tumor ablation and therapeutic immunity induction by an injectable peptide hydrogel. ACS Nano 12, 3295–3310 (2018).
Zhou, J. et al. Supply methods for melittin-based most cancers remedy. ACS Appl. Mater. Interfaces 13, 17158–17173 (2021).
Yu, X. et al. Melittin-lipid nanoparticles goal to lymph nodes and elicit a systemic anti-tumor immune response. Nat. Commun. 11, (2020).
Rady, I., Siddiqui, I. A., Rady, M. & Mukhtar, H. Melittin, a serious peptide element of bee venom, and its conjugates in most cancers remedy. Most cancers Lett. 402, 16–31 (2017).
Mascitelli, L. & Pezzetta, F. Fluvastatin and most cancers: Letter [1]. Int. J. Clin. Pract. 61, 168 (2007).
El-Aarag, B., Magdy, M., AlAjmi, M. F., Khalifa, S. A. M. & El-Seedi, H. R. Melittin exerts helpful results on paraquat-induced lung accidents in mice by modifying oxidative stress and apoptosis. Molecules 24, (2019).
Hardie, C., Jung, Y. & Jameson, M. Impact of statin and aspirin use on toxicity and pathological full response fee of neo-adjuvant chemoradiation for rectal most cancers. Asia. Pac. J. Clin. Oncol. 12, 167–173 (2016).
Browning, D. R. L. & Martin, R. M. Statins and danger of most cancers: A scientific evaluate and metaanalysis. Int. J. Most cancers 120, 833–843 (2007).
Dempsey, C. E. The actions of melittin on membranes. BBA Rev. Biomembranes 1031, 143–161 (1990).
Badr-Eldin, S. M. et al. Cytotoxic and pro-apoptotic results of a sub-toxic focus of fluvastatin on OVCAR3 ovarian most cancers cells after its optimized formulation to melittin nano-conjugates. Entrance. Pharmacol. 11, 642171 (2021).
Wong, R. S. Y. Apoptosis in most cancers: From pathogenesis to therapy. J. Exp. Clin. Most cancers Res. 30, 87 (2011).
Marie Hardwick, J. & Soane, L. A number of features of BCL-2 household proteins. Chilly Spring Harb. Perspect. Biol. 5, (2013).
Tsujimoto, Y. Position of Bcl-2 household proteins in apoptosis: Apoptosomes or mitochondria?. Genes Cells 3, 697–707 (1998).
Qi, X. F. et al. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by selling ROS era and regulating Akt, Erk and p38 alerts through suppression of mevalonate pathway. Cell Loss of life Dis. 4, e518 (2013).
Zhang, H. & Solar, S. C. NF-ΚB in irritation and renal ailments. Cell Biosci. 5, 1–12 (2015).
Liu, T., Zhang, L., Joo, D. & Solar, S. C. NF-κB signaling in irritation. Sign Transduct. Goal. Ther. 2, 17023 (2017).
